Cover
Cover | Jun. 04, 2020 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Amendment Description | This Amendment No. 1 to Current Report on Form 8-K ("Amendment No. 1") is being filed to amend the Current Report on Form 8-K filed by Cara Therapeutics, Inc. (the "Company") with the Securities and Exchange Commission on June 5, 2020 (the "Original 8-K"). Amendment No. 1 updates "Item 5.07 Submission of Matters to a Vote of Security Holders" in the Original 8-K to disclose the decision of the Company's Board of Directors (the "Board") on the frequency of holding a non-binding, advisory vote on executive compensation. No other changes have been made to the Original 8-K. |
Document Period End Date | Jun. 4, 2020 |
Entity File Number | 001-36279 |
Entity Registrant Name | CARA THERAPEUTICS, INC. |
Entity Central Index Key | 0001346830 |
Entity Tax Identification Number | 75-3175693 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 4 Stamford Plaza |
Entity Address, Address Line Two | 107 Elm Street |
Entity Address, Address Line Three | 9th Floor |
Entity Address, City or Town | Stamford |
Entity Address, State or Province | CT |
Entity Address, Postal Zip Code | 06902 |
City Area Code | 203 |
Local Phone Number | 406-3700 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, par value $0.001 per share |
Trading Symbol | CARA |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |